Bicytopenia and Abnormal Coagulation Profile in a Child with Influenza B: A RareCase Report
Keywords:
Influenza B, Child, Abnormal coagulation profile, BicytopeniaAbstract
Background:
Influenza B is a contagious respiratory illness that typically presents with acute febrile and respiratory symptoms. Hematologic abnormalities such as bicytopenia and coagulation disturbances are uncommon and may lead to diagnostic uncertainty.
Case Presentation:
We report a pediatric case of influenza B presenting with epistaxis, bicytopenia, and an abnormal coagulation profile during an outbreak. Laboratory evaluation revealed leukopenia, thrombocytopenia, and prolonged coagulation parameters. The diagnosis of influenza B was confirmed by nasopharyngeal swab polymerase chain reaction (PCR) testing. The patient was treated with oral oseltamivir, intravenous (IV) fluids, and paracetamol (acetaminophen). Clinical condition and laboratory abnormalities improved rapidly following antiviral therapy.
Conclusion:
Influenza B may present with transient hematologic abnormalities and coagulation disturbances, which can mimic more serious conditions. Awareness of such atypical presentations is essential to avoid unnecessary investigations, hospital admissions, and inappropriate antibiotic use. Further studies are needed to better characterize the hematologic spectrum associated with influenza B infection.
Downloads
References
1. Bennett JE, Blaser MJ. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 8th ed. Philadelphia (PA): Elsevier Saunders; 2015.
2. Shen CF, Huang SC, Wang SM, Wang JR, Liu CC. Decreased leukocytes and other characteristics of laboratory findings of influenza virus infections in children. J Microbiol Immunol Infect. 2008;41(4):294–300.
3. Grohskopf LA, Alyanak E, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2019–20 influenza season. MMWR Recomm Rep. 2019;68(3):1–21. doi:10.15585/mmwr.rr6803a1.
4. Subramaniam S, Scharrer I. Procoagulant activity during viral infections. Front Biosci (Landmark Ed). 2018;23(6):1060–1081. doi: 10.2741/4633.
5. Sedger LM, Hou S, Osvath SR, Glaccum MB, Peschon JJ, van Rooijen N, et al. Bone marrow B cell apoptosis during in vivo influenza virus infection requires TNF-alpha and lymphotoxin alpha. J Immunol. 2002;169(11):6193–201. doi:10.4049/jimmunol.169.11.6193.
6. Joob B, Wiwanitkit V. Thrombocytopenia: an important presentation of emerging H7N9 influenza. Platelets. 2014;25(4):308. doi:10.3109/09537104.2013.815342.
7. Sato M, Saito R, Sato I, Tanabe N, Shobugawa Y, Sasaki A, et al. Effectiveness of oseltamivir treatment among children with influenza A or B virus infections during four successive winters in Niigata City, Japan. Tohoku J Exp Med. 2008;214(2):113–20. doi:10.1620/tjem.214.113.
8. Ranka R, Kalita D, Panda PK. Influenza B presenting with bicytopenia in an adult–An unusual presentation and failure of antimicrobial stewardship by a practicing physician. J Family Med Prim Care. 2020;9(7):3737–3740. doi: 10.4103/jfmpc.jfmpc_711_20.
9. Armstrong SM, Darwish I, Lee WL. Endothelial activation and dysfunction in the pathogenesis of influenza A virus infection. Virulence. 2013;4(6):537–42. doi: 10.4161/viru.25779.
10. Le VB, Schneider JG, Boergeling Y, Berri F, Ducatez M, Guerin JL, et al. Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis. Am J Respir Crit Care Med. 2015;191(7):804–19. doi: 10.1164/rccm.201406-1031OC.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Muhammad Naveed Ashraf, Sania Ishtiaq Khan, John Twomey (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
